Spencer R. Berthelsen - 23 Jun 2021 Form 4 Insider Report for IONIS PHARMACEUTICALS INC (IONS)

Role
Director
Signature
By: Patrick R. O'Neil, attorney-in-fact For: Spencer R. Berthelsen
Issuer symbol
IONS
Transactions as of
23 Jun 2021
Net transactions value
-$426,600
Form type
4
Filing time
25 Jun 2021, 17:19:34 UTC
Next filing
06 Jul 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction IONS Common Stock Options Exercise $139,500 +15,000 +15% $9.30* 115,983 23 Jun 2021 Direct F1
transaction IONS Common Stock Sale $566,100 -15,000 -13% $37.74 100,983 23 Jun 2021 Direct F2
holding IONS Common Stock 70 23 Jun 2021 by Daughter F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IONS Non-Qualified Stock Option (right to buy) Options Exercise $0 -15,000 -100% $0.000000* 0 23 Jun 2021 Common Stock 15,000 $9.30 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Acquired as a result of exercising a stock option that was scheduled to expire on June 30, 2021. The purchase reported on this Form 4 was effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person March 12, 2021.
F2 Shares sold pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on March 12, 2021.
F3 The reporting person disclaims beneficial ownership of all securities held by his daughter, and this report should not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.